On December 20, 2018, the US Food and Drug Administration (FDA) issued a new warning against the use of fluoroquinolones in patients with connective tissue disorders and those predisposed to aortic disease.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Abdominal Aorta Infrarenal
January 18, 2011
Patient SelectionIndications for endovascular repair of the thoracic aortic aneurysm (Figure 1) are:
January 18, 2011
Patient Selection
Renal artery stenosis (RAS) of >70% of one or both renal arteries AND
poorly controlled hypertension despite multiple antihypertensive regimen, or
January 18, 2011
Patient Selection
Indications for endovascular repair of the abdominal aortic aneurysm are: